🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Yue Zou

Affiliated Hospital of Southwest Medical University

ORCID: 0000-0002-6999-8329
Immunology and MicrobiologyBiochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 8 papers. Top paper: “Targeting ribosome biogenesis as a novel therapeutic approach to overcome EMT-related chemoresistance in breast cancer”.

Targeting ribosome biogenesis as a novel therapeutic approach to overcome EMT-related chemoresistance in breast cancer

eLife(2023)10.7554/elife.89486
N/A
0.542DataRank · unranked
9 citations

Yue Zou, Y. Liu, S. S. Lee, Robert B. Bednarczyk, Jianting Sheng +4 more

Targeting Ribosome Biogenesis as a Novel Therapeutic Approach to Overcome EMT-related Chemoresistance in Breast Cancer

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.06.28.546927
N/A
0.165DataRank · unranked
2 citations

Yue Zou, Y. Liu, Sharrell B. Lee, Robert B. Bednarczyk, Jianting Sheng +4 more

IFNγ induces Bcl3 expression by JAK1/STAT1/p65 signaling, resulting in increased IL‐8 expression in ovarian cancer cells

FEBS Open Bio(2023)10.1002/2211-5463.13624
N/A
0DataRank · unranked
8 citations

Sveta Padmanabhan, Yue Zou, Mohammad M. Uddin, Suprataptha U. Reddy, Ivana Vancurova +1 more

Targeting Ribosome Biogenesis as a Novel Therapeutic Approach to Overcome EMT-related Chemoresistance in Breast Cancer

(2023)10.7554/elife.89486.1
N/A
0DataRank · unranked
1 citations

Yue Zou, Sharrell B. Lee, Robert B. Bednarczyk, Jianting Sheng, Yuliang Cao +3 more

Reviewer #3 (Public Review): Targeting Ribosome Biogenesis as a Novel Therapeutic Approach to Overcome EMT-related Chemoresistance in Breast Cancer

(2023)10.7554/elife.89486.1.sa0
N/A
0DataRank · unranked
0 citations

Yue Zou, Sharrell B. Lee, Robert B. Bednarczyk, Jianting Sheng, Yuliang Cao +3 more

IFNγ induces JAK1/STAT1/p65 NFκB-dependent interleukin-8 expression in ovarian cancer cells, resulting in their increased migration

The International Journal of Biochemistry & Cell Biology(2021)10.1016/j.biocel.2021.106093
N/A
0DataRank · unranked
24 citations

Bijaya Gaire, Yue Zou, Mohammad M. Uddin, Daniel DeLeon, Ivana Vancurova +1 more

Author response: Targeting Ribosome Biogenesis as a Novel Therapeutic Approach to Overcome EMT-related Chemoresistance in Breast Cancer

(2024)10.7554/elife.89486.2.sa0
N/A
0DataRank · unranked
0 citations

Yue Zou, Y. Liu, Sharrell Lee, Robert B. Bednarczyk, Jianting Sheng +4 more

IFNγ-induced PD-L1 expression in ovarian cancer cells is regulated by JAK1, STAT1 and IRF1 signaling

Cellular Signalling(2022)10.1016/j.cellsig.2022.110400
N/A
0DataRank · unranked
42 citations

Bijaya Gaire, Yue Zou, Mohammad M. Uddin, Ivana Vancurova, Sveta Padmanabhan